PHOENIX supports its customers to overcome difficulties bridging the “innovation valley of death”, enabling transfer of nanopharmaceuticals from lab bench to clinical trials. As an Open Innovation Test Bed (OITB), PHOENIX provides a Single-Entry-Point (SEP) for a network of facilities, technologies, services and expertise for all the R&D/I and technology transfer aspects from characterization, testing, verification up to scale-up, GMP manufacturing and regulatory guidance in a timely and cost-friendly manner.
Within this event, you will learn about the need for a European Single-Entry-Point and get to know the service providers offering expertise in the following areas:
- Physico-Chemical Characterisation
- In vitro Characterisation
- In vivo Characterisation
- Manufacturing
- Innovation (including regulatory aspects)
Austrian companies Research Center for Pharmaceutical Engineering (RCPE) and BioNanoNet Forschungsgesellschaft mbH are shareholders and RECENDT is a service provider.
We look forward to your participation and lively discussion in our online event!
Learn more about PHOENIX: https://www.phoenix-oitb.eu/satellite-event/
Register here: https://events.teams.microsoft.com/event/07728adb-4bcf-4234-82fe-1f02d42dd6eb@6a59fc34-fc91-4c44-8235-dd0a8ca2d891